A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness
A Comparative Study on Skin and Plasma Advanced Glycation End Products and Their Associations with Arterial Stiffness
复制标题
DOI:
10.1159/000453581
复制
发表时间:
2016-01-01
期刊:
影响因子:
--
通讯作者:
Wang, Ji-Guang
中科院分区:
文献类型:
--
作者:
Liu, Chang-Yuan;Huang, Qi-Fang;Wang, Ji-Guang
Background: We compared skin and plasma measurements of advanced glycation end products (AGEs), with particular focus on their levels in the presence of hypertension or diabetes and prediabetes and their associations with arterial stiffness in outpatients with suspected or diagnosed hypertension. Methods: Skin AGE accumulation was measured as autofluorescence on the left forearm using the skin autofluorescence Reader and expressed in arbitrary units in the range from 0 to 25. Plasma AGE concentration was measured by the enzyme linked immunosorbent assay method and logarithmically transformed for statistical analysis. Arterial stiffness was assessed by carotid-femoral pulse wave velocity (cfPWV) using the SphygmoCor system (Sydney, Australia). Results: The 218 participants (96 [44.0%] men, mean age 51.9 years) had a mean skin autofluorescence of 1.89 arbitrary units, plasma AGE concentration of 4.47 mu g/ml, and cfPWV of 8.0 m/s. Skin autofluorescence was significantly correlated with plasma AGEs in diabetic or prediabetic patients (n = 31, r = 0.37, p = 0.04) but not in subjects with normoglycemia (n = 187, r = 0.05, p = 0.48). Nonetheless, both measurements were significantly (p = 0.35). In adjusted multiple regression analyses, plasma AGE concentration, but not skin autofluorescence (p >= 0.37), was significantly associated with cfPWV in all subjects(beta 0.44 m/s for each 10-fold increase; p = 0.04) and in subgroups of men and diabetes and prediabetes (beta 0.12-0.55 m/s for each 10-fold increase; p